Cannabis
Germany: 51% of Regular Cannabis Consumer Plan to Grow Cannabis at Home
Germany’s cannabis legalization and the introduction of cannabis clubs mark major policy shifts. Since April 2024, adults can legally grow and possess cannabis. Studies show 44% of regular users plan to join clubs. Legal changes impact home cultivation and the medical market, with expected growth despite reduced imports. These changes significantly influence consumer habits and medical cannabis use.
The legalization of cannabis in Germany and the introduction of cannabis clubs are significant steps towards liberalizing drug policy in Europe.
As of April 2024, German adults can legally grow and possess cannabis in limited quantities. Recent studies, including the Pronova BKK survey, provide valuable data on consumption habits and plans to participate in cannabis clubs.
Pronova Bkk Survey results
The Pronova BKK survey was conducted in May 2024 among a representative sample of 1,000 German adults. The survey aimed to understand cannabis consumption habits and plans for cannabis clubs.
Key stats:
Regular Consumers: 44% of regular cannabis users plan to join a cannabis club.
Occasional consumers: 27% of occasional users expressed interest in joining the club.
Cannabis consumption among Germans: More than a quarter of Germans consume cannabis at least occasionally, and one tenth do so regularly on a weekly basis.
Consumption patterns among younger generations: Generation Z and those under the age of 45 show higher levels of cannabis consumption.
The impact of legalization on cannabis consumption
The survey found that for a third of consumers, legalisation had no significant impact on their habits. However, among younger respondents, one in ten have increased their cannabis use since the new regulations were introduced.
Considerations for Growing Cannabis at Home:
51% of regular consumers plan to grow cannabis at home.
40% of occasional users also express interest in home growing.
YouGov poll results
The YouGov poll, conducted in May 2024 among 3,375 German adults, concerned the purchase of cannabis seeds and clones.
Key data:
7% of German adults have already purchased cannabis seeds or clones.
11% plan to purchase seeds or clones in the future.
The popularity of home cultivation is growing, which is a direct result of the introduction of new legal regulations allowing the cultivation of up to three cannabis plants in private homes.
The introduction of cannabis clubs and changes in cannabis legislation are influencing consumer behaviour in Germany.
Changes in legislation and their impact
Since April 1st, 2024, new cannabis regulations have been in force in Germany, which have introduced significant changes:
Growing up to three plants in private homes: German adults can now legally grow up to three cannabis plants in their private homes.
Possession of up to 25 grams of cannabis outside your home: It is also legal to possess up to 25 grams of cannabis outside your home.
One of the most important legal changes was the removal of cannabis from the list of narcotics, which had a direct impact on the medical industry:
Easier prescribing of cannabis for doctors: Doctors now have simplified access to prescribing cannabis, making this therapy more accessible to patients.
Reduced Supply Chain Obstacles: The removal of cannabis from the narcotics list has reduced bureaucratic barriers in the supply chain for medical cannabis products, making their distribution faster and easier.
Medical cannabis market in Germany
Germany is currently the largest medical cannabis market in Europe. The country has seen significant growth in imports of medical cannabis products.
Germany as the largest medical cannabis market in Europe: Germany dominates the European medical cannabis market thanks to its liberal regulations and the growing number of patients using this form of therapy.
Medical cannabis import data for 2023: In 2023, Germany imported 31,398 kilograms of medical cannabis , an increase of 26.2% compared to 2022.
The introduction of new regulations in 2024 will likely impact the medical cannabis market:
Expected Reduction in Imports in 2024: Due to the possibility of home cultivation and the removal of domestic production quotas, imports of medical cannabis products are expected to significantly decrease in 2024.
Summary
The legalization of cannabis and the introduction of cannabis clubs in Germany have led to significant changes in consumer habits and the medical market. Studies such as Pronova BKK and YouGov provide valuable data on these changes.
Looking forward, cannabis clubs have the potential to become an important part of the cannabis community in Germany. The medical cannabis market is also expected to continue to grow, despite the expected decline in imports.
Regular research and surveys are key to monitoring changes in cannabis consumption and assessing the impact of new regulations on the market. They help us understand consumer trends and needs, which is essential for further developing market policies and strategies.
__
(Featured image by CRYSTALWEED cannabis via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne. A third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the originals will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Markets1 week ago
Markets Surge Amid Geopolitical Tensions, Debt Worries, and Chinese Stimulus
-
Markets3 days ago
Why the Markets Could Be Facing a Black Swan Event
-
Biotech1 week ago
Rovi Drags Down the Pharma Stock Market in September
-
Fintech1 day ago
Milan Fintech Summit: A Review of the 622 Italian Fintech Startups